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INTRODUCTION
Since many centuries ago, experts had continued
to study gastrointestinal (GI) tract function and its
protective mechanism. For many years, a lot of works
had been done in search of how intestine and stomach
can prevent damage from endogenous aggressive
substance such as digestive enzymes, gastric acid and
bile acids. Gastrointestinal tract always has direct
contact to external environment, and that is why it must
have some mechanism that can protect it from
dangerous substances and pathogenic microorganism
which enter digestive system together with food.
In normal condition, there is a balance between
aggressive factors and defensive factors which
maintain gastrointestinal mucosal integrity. In peptic
ulcer, defensive mechanism is outweighed by
intraluminal aggressive factors such as acids, pepsin,
NSAID and Helicobacter pylori.
Three hundreds and fifty years BC, Hypocrates had
mentioned about the symptoms of gastritis. In 1772
Hunter outlined first hypothesis of gastric protective
mechanism to autodigestion through adequate blood
flow. This was supported by Virchow (1853) who
believed that blood flow has acid neutralization effect.
The opinion that gastric mucosa produces acid had been
delivered by Prout (1823) and Beaumont (1826).
The role of acid in the pathogenesis of ulcer was
supported by Schwartz (1910) who conveyed No Acid,
No Ulcer dictum.
The role of mucus as one of defensive factors had
been endorsed by Glover (1800) and Harley (1860).
Paplov (1898) believed that mucus layer was alkali and
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Gastroduodenal mucosal integrity has important role in the pathogenesis of gastroduodenal ulcer.
It depends on imbalance between aggressive and defensive factors. However, many experts believe that
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induced GI injury and a potential target for therapeutic intervention.
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could neutralize acids. This was countered by Heatly
(1959) who stated that back diffusion of gastric acid
was neutralized by bicarbonate secreted by gastric
mucosa.1,2,3,4 Although recently it has been postulated
that peptic ulcer is due to imbalance between
aggressive and defensive factor, however, many
experts had concluded that defensive factors has
dominant role in maintenance of gastroduodenal
mucosal integrity.5
THE THREE LEVELS OF MUCOSAL DEFENSE
Almost in the last 3 decades, studies on defensive
mechanism of gastrointestinal tract were intensively
conducted. Recently, it has been widely accepted that
defensive mechanism involves 3 elements:1,4
1. Pre-epithelial factors that are secreted into
the lumen including mucus, acids, bicarbonate and
antibacterial substance like immunoglobulin, and
lactoferin. In this matter, the main function of acid
is to reduce amount of bacteria that entering
intestinal lumen. Mucus layer that covers
gastrointestinal tract from gaster to colon is
the frontline defense mechanism to aggressive
factors. Mucus functions as barrier to noxious
substances diffusion, trap for microorganism,
interact with immune system of gastrointestinal tract
and also acts as lubricant. Mucus is cohesive
compound of water (95%) and mucinous
glycoprotein (5%). Lipid is pressumed to have
important role in the formation and strengthening
of mucus.1,6
2. Epithelial factors consist of cell membrane,
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intercellular tight junction, plasma membrane and
restitution. Restitution is a rapid improvement
process of damaged epithelial cells by migrating
normal epithelial cells to damage epithelial cells.1,7,8
3. Subepithelial factors consist of mucosal blood flow,
nervous system, some inflammatory mediators and
immune system like macrophage and mast cells.
There are 2 cytoprotective mechanisms, adaptive
mechanism and direct cytoprotection. Adaptive
cytoprotection occurs because of formation of
endogenous prostaglandin due to contacts with mild
irritant substances, while direct cytoprotection is due
to exogenous prostaglandin.5,7
Several studies showed various factors that
influence cytoprotective mechanism. In 1985, Itoh and
Guth had proved that free radicals like superoxide had
important role in gastroduodenal mucosal damage. This
can be reduced by treatment using free radicals
scavenger such as superoxide dismutase (SOD).
Recently, it has been demonstrated the role of heat
shock protein/stressprotein in gastroduodenal mucosal
protection.5,6,7
THE ROLE OF INFLAMMATORY MEDIATORS
Gastroduodenal mucosal integrity depends on
the balance between defensive and aggressive factors
in the lumen. Some of components of gastroduodenal
mucosal defense are influenced by various
inflammatory mediators like nitric oxide (NO),
eicosanoid (prostaglandin, leucotrien, thromboxan),
platelet activating factor (PAF), neuropeptides,
cytokines and some proteinase enzymes.
1. Nitric oxide (NO)
There are some controversies regarding the role
of NO in GI tract whether it is protective or
destructive. However, many experts believe that
NO together with prostaglandin has become one
part of defensive factors through the following
mechanism:3,10
a. Modulate immunocytes activity of mucosa such
as mast cells and intestinal endothelial
permeability
b. Inhibit infiltration to GI mucosa
c. Reduce neutrophils adherence and secretion
d. Increase mucus and electrolyte secretion
Figure 2. NO contributes to mucosal defense in a number of
different ways.3
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CONCEPT OF CYTOPROTECTION
The findings of H2 receptor antagonist and proton
pump inhibitor can accelerate healing process of gastro
duodenal ulcer. However, recurrent ulcer can not be
fully prevented. The formation of ulcer is not always
induced by high acidity of gastric acid, especially in the
elderly which sometimes known to have low acidity
level of gastric acid.
In 1979, Robert et al reported that pretreatment of
gastric mucosa with oral or subcutaneous
prostaglandin (PGs) might prevent gastric necrosis
after contact with damaging substance such as
ethanol, HCl, NaOH, hypertonic NaCl and even heat.
This phenomenon is known as cytoprotection.
Cytoprotective mechanism is not related to acid
secretion. Although cytoprotective mechanism is not
wholly understood, it is presumed to have included
several points:3,5,7
- Prevent damage of gastric mucosal barrier
- Stimulate mucus production and bicarbonate
secretion
- Enhance mucosal blood flow to maintain adequate
oxygen supply for aerobic metabolism
- Induce cellular transport process and eliminate H+
back diffusion
- Stimulate macromolecule system
- Increase role of phospholipids and sulphydril at cell
surface
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2. Eicosanoid
a. Prostaglandin
Prostaglandin is formed from arachidonic acid
through cyclooxygenase (COX) enzyme activity. There
are 2 isoform of COX; COX-1 and COX-2.
Prostaglandin that is produced by COX-1 pathway has
defensive factor properties on GI tract:
- Stimulate mucus secretion and bicarbonate
- Maintain optimal mucosal blood flow
- Increase resistance of epithelial cells to damage
due to cytotoxin
- Inhibit leukocyte infiltration if there is mucosa
inflammation
Meanwhile, prostaglandin which is produced through
COX-2 pathway has detrimental effect because of its
pro-inflammatory property will cause edema, fever and
pain. In this context, recently, new class of drugs that
selectively inhibit COX-2 have been developed, so that
they may have more potent anti inflammation and
analgesic effect but less ulcerogenic.
2. Stimulate oxygen reactive metabolite secretion from
neutrophils which will cause mucosal inflammation
3. In the pathogenesis of NSAID gastropathy, LTB4
will stimulate leukocyte adherence to epithelial
vascular vessel. The same thing happens in the
pathogenesis of ulcer due to Helicobacter pylori
infection
4. Has role in pathogenesis of inflammatory bowel
disease (IBD)
The bad influence of peptidoleukotrien on GI
mucosa is presumed through increased endothelial
vascular permeability and increased secretion of selectin
P and mast cell activation.
c.  Thromboxan
Thromboxan is main metabolite of arachidonic acid
produced by thrombocytes (through COX-1).
Thromboxan is a potent vasoconstrictor and anti
 thrombocyte aggregation. It has role in inducing
gastroduodenal ulcer because it can reduce mucosal
blood flow, stimulate formation of LTB4, increase
leukocyte adherence and thus increase inflammatory
response.
3. Platelet Activating Factor (PAF)
PAF is produced from phospholipids through
activation of phospholipase enzyme. PAF is a potent
ulcerogenic factor. The role of PAF in the destruction
of gastroduodenal mucosa is believed through its
effects to increase leukocyte adherence of endothelial
vessel and activation of granulocytes to secrete
oxygen reactive metabolite. In small intestine, PAF is
presumed to have role in process of neutrophils
infiltration to lamina propria in the case of
helminthiasis. PAF is also presumed to have role in the
pathogenesis of neonatal necrotizing enterocolitis and
IBD.
4. Neuropeptides
Peptide mediators produced by intrinsic and
extrinsic nerve fibers of GI tract. One of
neuropeptides that has important role in defensive
mechanism of GI tract is calcitonin-gene related
peptide (CGRP). If there are irritant substances in
gastric lumen, CGRp is released by the sensory
afferent nerve fibers whichinduce NO release from
endothelial vascular and cause dilatation of submucosal
arterioles. This will increase mucosal blood flow which
helps dilute, neutralize or even hamper back diffusion
of acid and toxins/irritants. Mucosal defensive
mechanism through CGRP is inhibited by capcaisin.1,3
Mast cell has role in defensive mechanism of
gastric mucosa like CGRP. Afferent sensory nerves in
GI tract can release P substance which will activate
mast cell to release histamine that causes submucosal
arteriole dilatation/hyperemic mucosa of GI tract as
part of defensive mechanism to intraluminal irritant
substances.
However, nowadays there are still questions on
the role of COX, especially known as COX-2
hypothesis, because evidences were rather against the
theory above:3,11
a. Some COX-2 inhibitors only induce anti-
inflammatory effect on experimental rats if it was
given at dose that also inhibit COX-1
b. Giving the selective inhibitor COX-2 to
experimental rats had minimal effect to GI tract,
but in fact, there are still many reports on
the incidence of ulcer or bleeding or perforation
even after consumption of these drugs
b.  Leukotrien 3,10
Leukotrien is synthesized from arachidonic acids
through 5-lypooxygenase enzyme activity. There are
2 kinds of leukotriens B4 (LTB4) and peptidoleukotrien.
Synthesis of leukotrien occurs mainly in immnunocytes
especially mast cells, epithelial cells and endothelial
cells. The two leukotrients have bad impact on GI
mucosa. The impacts of LTB4 on GI tract:
1. Induce leukocyte infiltration
Figure 3. Schematic diagram of the relative roles of COX-1 and
COX-23
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5. Cytokine
Cytokine has important role in regulation of
mucosal GI immune system especially in the intestine
and colon. One of main factors in the pathogenesis of
IBD is presumed due to imbalance production between
pro and anti-inflammatory cytokines. Three widely
known cytokines are interleukin-1β (IL-1β), Tumor
Necrosis Factor-α (TNF-α) which have
pro-inflammatory properties and interleukin-10 (IL-10)
which has the anti-inflammatory property. In patients
with IBD, there is increased level of plasma IL-1.
IL-β, and TNF-α that are released in early phase of
inflammation and infection, have effects on appetite
and induce fever. As mater of fact for the upper GI
tract, for example in cases of NSAID gastropathy,
IL-1, on the contrary, could reduce mucosal damage
by inhibiting to leukocyte adherence, stimulate
prostaglandin and NO release. IL-1 also inhibits
the release of ulcer promoting mediators such as PAF
and histamine from mast cells. Meanwhile, TNF-α has
role in mechanism of gastric mucosal damage in
association with Helicobacter pylori infection.2,6
Prostaglandin is a potent inhibitor of TNF-α release
by macrophage and mast cells. TNF-α is also assumed
to have role in the pathogenesis of IBD.
IL-10 is mainly produced by lymphocyte cells of
Th2, Th1 and monocyte. IL-10 suppresses production
of pro-inflammatory cytokines. Akagi et al2 reported
increased TNF-α and interpheron-γ level, decreased
IL-10 in patients with Crohn’s disease.
6.  Proteinase
Proteinase (e.g. thrombin, tripsin, and triptase) has
role in protein degradation and cell regulation through
breakdown of proteinase activated receptors (PARs)
which is part of protein G receptor. We have known 4
kinds of PARs; PARs 1, Pars 2, Pars 3 and PARs 4,
generally released by spinal afferent nerve fibers.
Activation of PARs causes release of neuro-
transmitters that modulate mucosal GI defensive
mechanism.
THE ROLE OF NUTRIENT ON GASTROINTESTINAL
MUCOSAL INTEGRITY 12,13
Gastrointestinal acts as barrier to external
environment and main entrance of nutrient. In order to
maintain both functions, intestinal epithelial depend much
on nutrition from lumen and blood flow. In case of
maintenance of mucosal integrity, there are some
nutrients which have role in it such as glutamine,
vitamin A, vitamin E, probiotic and prebiotic.
Glutamine
Glutamine has important role in rapid turn over of
cells including intestinal cells. Glutamine from food is
assumed to have important role in glutathione
synthesis of gastrointestinal and acts as one of
antioxidant.
Arginin
Arginin is an amino acid which has role in nitrogen
transport and excretion as precursor of NO
functioning in maintenance of gastrointestinal mucosal
integrity.
Vitamin A
Vitamin A has important role in preservation of
epithelial cell integrity, immune function and retinal
function. Deficiency of vitamin A cause disturbance
of barrier function from gastrointestinal tract. Studies
on experimental rats with vitamin A deficiency showed
reduced intestinal cells differentiation and reduced
goblect cells in crypti and vilus.
Vitamin C and E
In experimental rats which were exposure to
X-ray, both vitamin C and E gave protective effect
through dual mechanism. First, as the anti oxidant for
free radicals and second indirectly strengthen mucosal
barrier by increasing synthesis and secretion of
prostaglandin which will increase thickness of mucus
and phospholipids layer.
Probiotic
Probiotic is defined as microorganism in food which
is fermented and has role in maintaining the balance of
intestinal microflora such as lactobacillus and
bifidobacteria. Probiotic increases immune system of
intestinal mucosa both in experimental animal and
human. Human study indicated probiotic could prevent
traveler diarrhea due to Eschericia coli and
presumably also had theurapeutic effect in patients with
IBD.
Prebiotic
Prebiotics is nondigestable food which had
favorable effect to human body by stimulating
selectively certain commensally bacterial growth and
activity in colon. Oligosacharydes derived from
various plants such as onion or banana can stimulate
growth of bifidobacteria and lactobacillus in colon.
Direct actions of prebiotics on gastrointestinal tract
are improved intestinal function, increase luminal
absorption, increase lipid metabolism and reduce risk
of colon cancer.
THE ROLE OF MEDICATION
Recently, many researches had been conducted to
find drugs that can increase defensive capacity of
gastric mucosa. One of them is teprenone which is a
polyisoprenoid derived from vitamin A.14,15
Protective effect of teprenone is presumed through
following mechanisms:
- Increase glycoprotein content of gastric mucus and
mucus layer, preserve normal structure of mucus
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and inhibit glycoprotein reduction of mucus by
aspirin
- Increase hidrophobicity of gastric mucosa
- Increase endogenous prostaglandine level
- Increase blood flow and gastric mucosa regeneration
- Direct action as free radical scavenger
- Teprenone had been proven to have capacity to
induce heat shock protein (HSP) as mucosal
cytoprotection
CONCLUSION
- In normal condition, there is balance between
aggressive and defensive factors to maintain
gastrointestinal mucosal integrity
- Mucosal defensive mechanism of gastrointestinal
tract involves three elements which are
pre-epithetlial, epithelial, and subepithelial factors
- Various kinds of inflammatory mediators such as
NO, eicosanoid (prostaglandin, leukotrien and
thromboxan), PAF, neuropeptide, cytokine and
proteinase and some nutrients known as functional
food have impact on gastrointestinal mucosal
integrity
- Some of medications that already known
(e.g. teprenone) can increase gastric mucosal
defensive capacity
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